Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
Ann Thorac Surg. 2012 Nov;94(5):1478-84. doi: 10.1016/j.athoracsur.2012.05.030. Epub 2012 Jul 7.
We aimed to determine whether the reported late survival benefit of radial artery (RA) versus saphenous vein (SV) grafting in the general coronary artery bypass graft surgery (CABG) population is maintained in elderly patients aged 70 years or older.
We reviewed our 1996 to 2007 experience in 2,120 elderly patients (RA, n = 607; SV, n = 1,513) who underwent primary, nonsalvage CABG with multiple completed grafts including at least one internal thoracic artery (ITA) graft. Patients were excluded in case of single-vessel disease, bilateral ITA, ITA-only grafts, or concomitant valve/aortic surgery. Kaplan-Meier 12-year survival estimates were compared for 1-to-1 matched ITA/RA and ITA/SV cohorts based on a nonparsimonious RA use propensity model (48 variables).
The ITA/RA and ITA/SV cohorts (both, aged 75 ± 4yrs and 3.5 ± 0.8 grafts) were well matched and had identical operative mortality (2.3%; 11 of 480 each). Late survival was superior ITA/RA versus ITA/SV (p < 0.001), estimated at 85.1% versus 70.6% and 70.9% versus 50.5% for 5 and 10 years, respectively. Late survival risk ratios (95% confidence interval) for RA versus SV grafting was 0.47 (0.36 to 0.61), and the relative SV to RA death hazard was greater than 1 between 1 and 144 months.
The late survival results suggest that elderly (≥70 years) primary multivessel CABG patients benefit substantially when RA is used as the second conduit in combination with ITA. Indeed, compared with previously published comparisons including all age groups, the derived risk ratio indicates that the benefit for the elderly may exceed that for younger patients in the initial decade after CABG. Use of RA should not be avoided in the elderly.
我们旨在确定在一般冠状动脉旁路移植术(CABG)人群中,桡动脉(RA)与隐静脉(SV)搭桥报告的晚期生存获益是否在 70 岁及以上的老年患者中得到维持。
我们回顾了我们在 1996 年至 2007 年间对 2120 名老年患者(RA 组,n=607;SV 组,n=1513)的经验,这些患者接受了初次、非抢救性 CABG,并且有至少一条胸廓内动脉(ITA)桥接。如果存在单支血管病变、双侧 ITA、仅 ITA 桥接或合并瓣膜/主动脉手术,则排除患者。根据非简约的 RA 使用倾向模型(48 个变量),对 1:1 匹配的 ITA/RA 和 ITA/SV 队列进行了 12 年生存估计的 Kaplan-Meier 比较。
ITA/RA 和 ITA/SV 队列(均为 75±4 岁和 3.5±0.8 个桥接)匹配良好,手术死亡率相同(2.3%;各有 11 例/480 例)。ITA/RA 组的晚期生存率优于 ITA/SV 组(p<0.001),5 年和 10 年的估计生存率分别为 85.1%和 70.6%,70.9%和 50.5%。RA 与 SV 桥接的晚期生存风险比(95%置信区间)为 0.47(0.36 至 0.61),SV 相对于 RA 的死亡危险在 1 至 144 个月时大于 1。
晚期生存结果表明,当 RA 作为 ITA 的第二种桥接在 70 岁及以上的老年多支血管 CABG 患者中使用时,这些患者会显著获益。事实上,与包括所有年龄组的先前发表的比较相比,得出的风险比表明,在 CABG 后的最初十年中,老年患者的获益可能超过年轻患者。在老年患者中不应该避免使用 RA。